Simon Correa Gaviria, MD, MMSc
Cards
Contact Info
About
Titles
Hospital Resident
Biography
I am physician-scientist invested in improving cardiovascular health among those with kidney disease. Soon after graduating from University of Antioquia Medical School (Colombia), I worked as a general practitioner directing programs for non-communicable diseases with a special focus on cardiovascular disease prevention. I then joined the Harvard Medical School’s Master of Medical Science in Clinical Investigation Class of 2018. During my master’s program, I spent two years at the TIMI study group investigating cardiovascular disease (CVD) in chronic kidney disease (CKD) and worked as a medical reviewer for the safety desk. Upon graduation, I joined the Mc Causland Lab at the Renal Division of Brigham and Women's Hospital, extending my research on CVD in CKD to end-stage renal disease and hemodialysis. My research encompasses observational studies looking at predictors of intradialytic hypotension with a special focus on neurohormonal axes, studies evaluating risk factors for progression of CKD and CVD, the use of point-of-care devices in hemodialysis and clinical trials assessing interventions to prevent intradialytic hypotension. I am interested in conducting clinical trials in CKD and ESRD and I was member of the Clinical Endpoint Center (CEC) at Brigham and Women’s Hospital where I participated adjudicating clinical events for NIH- and industry-sponsored phase 3 trials. I hope to become the next cardiorenal trialist, bridging the gap between the kidney and the heart.
Education & Training
- MMSc
- Harvard Medical School (2018)
- MD
- Universidad de Antioquia (2014)
Research
Overview
Medical Subject Headings (MeSH)
Research at a Glance
Publications Timeline
Publications
2023
Time of hemodialysis and risk of intradialytic hypotension and intradialytic hypertension in maintenance hemodialysis.
Alostaz M, Correa S, Lundy GS, Waikar SS, Mc Causland FR. Time of hemodialysis and risk of intradialytic hypotension and intradialytic hypertension in maintenance hemodialysis. J Hum Hypertens 2023 PMID: 36599899, DOI: 10.1038/s41371-022-00799-2.Peer-Reviewed Original Research
2021
Serum Magnesium, Blood Pressure, and Risk of Hypertension and Chronic Kidney Disease Progression in the CRIC Study.
Correa S, Guerra-Torres XE, Waikar SS, Mc Causland FR. Serum Magnesium, Blood Pressure, and Risk of Hypertension and Chronic Kidney Disease Progression in the CRIC Study. Hypertension 2021, 78: 1771-1780. PMID: 34757763, DOI: 10.1161/HYPERTENSIONAHA.121.17694.Peer-Reviewed Original ResearchA randomized controlled trial of two dialysate sodium concentrations in hospitalized hemodialysis patients.
Causland FRM, Ravi KS, Curtis KA, Kibbelaar ZA, Short SAP, Singh AT, Correa S, Waikar SS. A randomized controlled trial of two dialysate sodium concentrations in hospitalized hemodialysis patients. Nephrology, Dialysis, Transplantation : Official Publication Of The European Dialysis And Transplant Association - European Renal Association 2021 PMID: 34792161, DOI: 10.1093/ndt/gfab329.Peer-Reviewed Original ResearchRisk of Intradialytic Hypotension by Day of the Week in Maintenance Hemodialysis.
Correa S, Guerra-Torres XE, Ravi KS, Mothi SS, Waikar SS, Mc Causland FR. Risk of Intradialytic Hypotension by Day of the Week in Maintenance Hemodialysis. ASAIO Journal (American Society For Artificial Internal Organs : 1992) 2021 PMID: 34494985, DOI: 10.1097/MAT.0000000000001576.Peer-Reviewed Original ResearchPredialysis serum phosphate and intradialytic hypotension.
Ravi KS, Reeves PB, Correa S, Neves JS, Waikar SS, Mothi SS, Mc Causland FR. Predialysis serum phosphate and intradialytic hypotension. Hemodialysis International. International Symposium On Home Hemodialysis 2021 PMID: 34236130, DOI: 10.1111/hdi.12971.Peer-Reviewed Original ResearchSerum Myeloperoxidase, Uric Acid, and the Risk of Atrial Fibrillation in Chronic Kidney Disease.
Correa S, Curtis KA, Waikar SS, Mc Causland FR. Serum Myeloperoxidase, Uric Acid, and the Risk of Atrial Fibrillation in Chronic Kidney Disease. Circulation. Arrhythmia And Electrophysiology 2021, 14: e009483. PMID: 33858180, DOI: 10.1161/CIRCEP.120.009483.Peer-Reviewed Original ResearchLeveraging Deep Learning to Improve Safety of Outpatient Hemodialysis.
Correa S, Mc Causland FR. Leveraging Deep Learning to Improve Safety of Outpatient Hemodialysis. Clinical Journal Of The American Society Of Nephrology : CJASN 2021, 16: 343-344. PMID: 33574057, PMCID: PMC8011011, DOI: 10.2215/CJN.00450121.Peer-Reviewed Original ResearchSpecific Electrocardiograph Intervals Predict Hospitalization with Atrial Fibrillation in Those with Chronic Kidney Disease.
Scovner KM, Correa S, Claggett BL, Barrett CD, Waikar SS, Solomon SD, Mc Causland FR. Specific Electrocardiograph Intervals Predict Hospitalization with Atrial Fibrillation in Those with Chronic Kidney Disease. American Journal Of Nephrology 2021, 52: 412-419. PMID: 33951623, PMCID: PMC8263478, DOI: 10.1159/000515670.Peer-Reviewed Original ResearchAssociation Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19
Gupta S, Wang W, Hayek SS, Chan L, Mathews KS, Melamed ML, Brenner SK, Leonberg-Yoo A, Schenck EJ, Radbel J, Reiser J, Bansal A, Srivastava A, Zhou Y, Finkel D, Green A, Mallappallil M, Faugno AJ, Zhang J, Velez JCQ, Shaefi S, Parikh CR, Charytan DM, Athavale AM, Friedman AN, Redfern RE, Short SAP, Correa S, Pokharel KK, Admon AJ, Donnelly JP, Gershengorn HB, Douin DJ, Semler MW, Hernán MA, Leaf DE, Walther C, Anumudu S, Arunthamakun J, Kopecky K, Milligan G, McCullough P, Nguyen T, Shaefi S, Krajewski M, Shankar S, Pannu A, Valencia J, Waikar S, Kibbelaar Z, Athavale A, Hart P, Upadhyay S, Vohra I, Oyintayo A, Green A, Rachoin J, Schorr C, Shea L, Edmonston D, Mosher C, Shehata A, Cohen Z, Allusson V, Bambrick-Santoyo G, Bhatti N, Mehta B, Williams A, Brenner S, Walters P, Go R, Rose K, Hernán M, Lisk R, Zhou A, Kim E, Chan L, Mathews K, Coca S, Altman D, Saha A, Soh H, Wen H, Bose S, Leven E, Wang J, Mosoyan G, Nadkarni G, Pattharanitima P, Gallagher E, Friedman A, Guirguis J, Kapoor R, Meshberger C, Kelly K, Parikh C, Garibaldi B, Corona-Villalobos C, Wen Y, Menez S, Malik R, Cervantes C, Gautam S, Mallappallil M, Ouyang J, John S, Yap E, Melaku Y, Mohamed I, Bajracharya S, Puri I, Thaxton M, Bhattacharya J, Wagner J, Boudourakis L, Nguyen H, Ahoubim A, Kashani K, Tehranian S, Thomas L, Sirganagari D, Guru P, Zhou Y, Bergl P, Rodriguez J, Shah J, Gupta M, Kumar P, Lazarous D, Kassaye S, Melamed M, Johns T, Mocerino R, Prudhvi K, Zhu D, Levy R, Azzi Y, Fisher M, Yunes M, Sedaliu K, Golestaneh L, Brogan M, Kumar N, Chang M, Thakkar J, Raichoudhury R, Athreya A, Farag M, Schenck E, Cho S, Plataki M, Alvarez-Mulett S, Gomez-Escobar L, Pan D, Lee S, Krishnan J, Whalen W, Charytan D, Macina A, Chaudhry S, Wu B, Modersitzki F, Srivastava A, Leidner A, Martinez C, Kruser J, Wunderink R, Hodakowski A, Velez J, Price-Haywood E, Matute-Trochez L, Hasty A, Mohamed M, Avasare R, Zonies D, Leaf D, Gupta S, Sise M, Newman E, Omar S, Pokharel K, Sharma S, Singh H, Correa S, Shaukat T, Kamal O, Wang W, Yang H, Boateng J, Lee M, Strohbehn I, Li J, Mueller A, Redfern R, Cairl N, Naimy G, Abu-Saif A, Hall D, Bickley L, Rowan C, Madhani-Lovely F, Peev V, Reiser J, Byun J, Vissing A, Kapania E, Post Z, Patel N, Hermes J, Sutherland A, Patrawalla A, Finkel D, Danek B, Arikapudi S, Paer J, Cangialosi P, Liotta M, Radbel J, Puri S, Sunderram J, Scharf M, Ahmed A, Berim I, Vatson J, Anand S, Levitt J, Garcia P, Boyle S, Song R, Arif A, Zhang J, Woo S, Deng X, Katz-Greenberg G, Senter K, Sharshir M, Rusnak V, Ali M, Peters T, Hughes K, Bansal A, Podoll A, Chonchol M, Sharma S, Burnham E, Douin D, Rashidi A, Hejal R, Judd E, Latta L, Tolwani A, Albertson T, Adams J, Chang S, Beutler R, Schulze C, Macedo E, Rhee H, Liu K, Jotwani V, Koyner J, Shah C, Jaikaransingh V, Toth-Manikowski S, Joo M, Lash J, Neyra J, Chaaban N, Elias M, Ahmad Y, Iardino A, Au E, Sharma J, Sosa M, Taldone S, Contreras G, Zerda D, Fornoni A, Gershengorn H, Hayek S, Blakely P, Berlin H, Azam T, Shadid H, Pan M, O’ Hayer P, Meloche C, Feroze R, Padalia K, Bitar A, Leya J, Donnelly J, Admon A, Flythe J, Tugman M, Chang E, Brown B, Leonberg-Yoo A, Spiardi R, Miano T, Roche M, Vasquez C, Bansal A, Ernecoff N, Kapoor S, Verma S, Chen H, Kovesdy C, Molnar M, Azhar A, Hedayati S, Nadamuni M, Shastri S, Willett D, Short S, Renaghan A, Enfield K, Bhatraju P, Malik A, Semler M, Vijayan A, Joy C, Li T, Goldberg S, Kao P, Schumaker G, Goyal N, Faugno A, Hsu C, Tariq A, Meyer L, Kshirsagar R, Jose A, Weiner D, Christov M, Griffiths J, Gupta S, Kapoor A, Wilson P, Arora T, Ugwuowo U. Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19. JAMA Internal Medicine 2021, 181: 41-51. PMID: 33080002, PMCID: PMC7577201, DOI: 10.1001/jamainternmed.2020.6252.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsMeSH KeywordsAdolescentAdrenal Cortex HormonesAdultAgedAntibodies, Monoclonal, HumanizedAnticoagulantsCohort StudiesCOVID-19COVID-19 Drug TreatmentCritical IllnessEarly Medical InterventionFemaleHospital MortalityHospitalizationHumansIntensive Care UnitsMaleMiddle AgedMortalityOrgan Dysfunction ScoresPatient PositioningProne PositionProportional Hazards ModelsReceptors, Interleukin-6Respiration, ArtificialRespiratory InsufficiencySARS-CoV-2Young AdultConceptsIntensive care unitICU admissionIll patientsCohort studyHazard ratioInverse probability weightingCOVID-19Severe COVID-19 illnessTocilizumab-treated patientsCytokine release syndromeMulticenter cohort studyDay of admissionCox regression modelRandomized clinical trialsCOVID-19 illnessCoronavirus disease 2019Interleukin-6 receptorHospital mortalityRelease syndromeIll adultsCare unitIllness characteristicsClinical trialsTocilizumabEarly treatmentElectrolyte Changes in Contemporary Hemodialysis: A Secondary Analysis of the Monitoring in Dialysis Study
Correa S, Scovner KM, Tumlin JA, Roy-Chaudhury P, Koplan BA, Costea AI, Kher V, Williamson D, Pokhariyal S, McClure CK, Mc Causland FR, Charytan DM, on behalf of the MiD Investigators and Committees, MiD Investigators and Committees. Kidney360 Apr 2021, 2 (4) 695-707; DOI: 10.34067/KID.0007452020Peer-Reviewed Original Research
Academic Achievements and Community Involvement
activity Reviewer
Journal ServiceCirculationDetails2020 - Presentactivity Reviewer
Journal ServiceClinical Journal of the American Society of NephrologyDetails02/01/2020 - Presentactivity Reviewer
Journal ServiceJournal of the American Heart AssociationDetails02/01/2020 - Presentactivity Reviewer
Journal ServiceKidney360Details02/01/2020 - Presentactivity Reviewer
Journal ServiceJournal of Thrombosis and ThrombolysisDetails02/01/2019 - Present